 |
|
|
 |
|
|
| Ali H. Brivanlou, Ph.D. |
|
Professor and Head
Laboratory of Molecular Vertebrate Embryology |
|
| Paul Greengard, Ph.D. |
|
Vincent Astor Professor & Head
Laboratory of Molecular & Cellular Neuroscience |
|
| Roderick MacKinnon, M.D. |
|
John D. Rockefeller Jr. Professor and Head
Laboratory of Molecular Neurobiology & Biophysics
Investigator, HHMI |
|
| Tom Muir, Ph.D. |
|
Professor and Head, Selma and Lawrence Ruben Laboratory of Synthetic Protein Chemistry |
|
| Paul Nurse, Ph.D. |
|
President, The Rockefeller University and Head, Laboratory of Yeast Genetics and Cell Biology |
|
| Jeffrey Ravetch, M.D., Ph.D. |
|
Theresa and Eugene M. Lang Professor and Head
Wagner Laboratory of Molecular Genetics and Immunology |
|
| Hermann Steller, Ph.D. |
|
Strang Professor of Cancer Biology
Investigator, HHMI |
|
 |
|
|
| Ms. Judith Roth Berkowitz |
|
Jarby, Inc. |
|
Anthony B. Evnin, Ph.D. |
|
General Partner; Venrock |
|
| Mr. G. S. Beckwith Gilbert |
|
President & CEO; Field Point Capital Management |
|
| Dr. David I. Hirsh, '68 |
|
Robert Wood Johnson, Jr. Professor
Columbia University |
|
| Mrs. Robin Chemers Neustein |
|
Goldman, Sachs & Co. |
|
 |
|
|
| Mr. David Elliman |
|
Elmrock Capital, Inc. |
|
| Dr. Louis Herlands, '87 |
|
President; Dara Pharmaceuticals, Inc. |
|
| Paul J. Maddon, M.D., Ph.D. |
|
Chairman & CEO; Progenics Pharmaceuticals, Inc. |
|
| Mrs. Andrea Mendell |
|
New York, NY |
|
| Mr. Thomas G. Mendell |
|
The Beacon Group, L.P. |
|
| Mr. Lyle Miller |
|
Managing Director, Morgan Stanley |
|
| Mr. John J. Moore, Jr. |
|
Managing Director, Investment Banking Division
Morgan Stanley |
|
| Mr. Russell P. Pennoyer |
|
Benedetto, Gartland & Company |
|
 |
|
|
| Niva Almaula, Ph.D. |
|
Consultant, BIO-IB, LLC; New York, NY |
|
| Mr. Graham D.S. Anderson |
|
General Partner, EuclidSR Partners; New York, NY |
|
| Steven C. Bailey, Ph.D. |
|
General Partner, Trillium Medical Ventures LLC
New York, NY |
|
| Geraldine Baldwin, Ph.D. |
|
Partner, Jones Day; New York, NY |
|
| Ms. Kenna Baudin |
|
Associate, Solera Capital; New York, NY |
|
| Mr. John Bernstein |
|
President, The Leon Levy Foundation; New York, NY |
|
| Dr. Laurence Blumberg |
|
Managing Member, Blumberg Capital Management
New York, NY |
|
| Mr. Robi Blumenstein |
|
MRSSI/High Q Foundation; New York, NY |
|
| Tom Brakel, M.D. |
|
New York, NY |
|
| Mrs. Marilyn Breslow |
|
President, W. P. Stewart, Inc.; New York, NY |
|
| Ms. Valerie Brown |
|
Director, Corporate Development
Bristol-Myers Squibb Company; New York, NY |
|
| Mr. Steven Burrill |
|
Burrill and Company; San Francisco, CA |
|
| Ms. Leah Rush Cann |
|
Senior Analyst, Wachovia/First Union Securities
New York, NY |
|
| Ronald D. Carroll, Ph.D. |
|
VP & CTO, Pharmaceutical Technologies
Cambrex Corporation |
|
| John Choi, M.D., Ph.D. |
|
Associate, Venrock Associates; New York, NY |
|
| Ms. Meirav Chovav |
|
Managing Director, UBS; New York, NY |
|
| Lupe Cipres, Ph.D. |
|
Analyst, Trillium Medical Ventures; New York, NY |
|
| Mr. Timothy J. Clark |
|
Managing Member; Elm Street Capital Partners LLC |
|
| Magdalene K. Cook, M.D. |
|
Principal, Perseus-Soros
Biopharmaceutical Fund, LLC |
|
| Fred Craves, Ph.D. |
|
Managing Director, Bay City Capital
San Francisco, CA |
|
| Barbara Dalton, Ph.D. |
|
General Partner; EuclidSR Partners |
|
| Mr. Derik de Bruin |
|
Director, UBS; New York, NY |
|
| Mr. John de Souza |
|
Investment Management Division; Goldman Sachs |
|
| Ms. Teresa Dereniak |
|
Vice President, Investor Growth Capital, Inc.
New York, NY |
|
| Richard D. DiMarchi, Ph.D. |
|
Professor and Linda & Jack Gill Chair
in Biomolecular Sciences, Indiana University |
|
| Frank L. Douglas, M.D., Ph.D. |
|
Executive Director, MIT Center for Biomedical Innovation |
|
| Ken Drazan, M.D. |
|
ArgiNOx, Inc.; Cold Spring Harbor, NY |
|
| Christopher D. Earl, Ph.D. |
|
Managing Director, Perseus-Soros Biopharmaceutical Fund |
|
| Ms. Yvette Borofsky Edidin |
|
Solera Capital, LLC; New York, NY |
|
| Ms. Joyce Erony |
|
Venture Partner, Bay City Capital, New York, NY |
|
| Allen A. Fienberg, Ph.D. |
|
Founder & Vice President of Business Development
Intra-Cellular Therapies |
|
| Ansbert Gadicke, M.D. |
|
MPM Capital; Cambridge, MA |
|
| Allan R. Goldberg, Ph.D. |
|
Managing Partner, The Channel Group; New York, NY |
|
| Mr. Seymour Goldblatt |
|
S-Squared Technology Corp.
New York, NY |
|
| Mr. Henry E. Gooss |
|
Managing Director, Investor Growth Capital, Inc.
New York, NY |
|
| Rahul Gopalkrishnan, Ph.D. |
|
Scientific Advisor, Baker Botts LLP; New York, NY |
|
| Kenneth Gorelick, M.D. |
|
Chief Operating Officer, Enzybiotics LLC |
|
|
| Myles Greenberg, M.D. |
|
CHL Medical Partners, L.P. |
|
| Leo Guthart, Ph.D. |
|
Topspin Partners, L.P. |
|
| Ms. Victoria Hamilton |
|
Director, The Washington Advisory Group
New York, NY |
|
| Ms. Victoria Hartman |
|
Portfolio Director, Woodcock Financial Management
New York, NY |
|
| Mr. Kent Hawryluk |
|
General Partner, Twilight Venture Partners, LLC
Indianapolis, IN |
|
| Mr. Charles D. Hodgkins, III |
|
Associate, Collinson, Howe & Lennox, LLC
Stamford, CT |
|
| Elaine V. Jones, Ph.D. |
|
General Partner, Euclid SR Partners; New York, NY |
|
| Mr. J. Mark Junewicz |
|
President, Junewicz & Co., Inc.; New York, NY |
|
| Mr. Stephen Katz |
|
President, Katz Associates |
|
| Ms. Karen E. Kerr |
|
Agile Equities; New York, NY |
|
| Mr. Colin King |
|
Goldman Sachs |
|
| Peter Kosa, Ph.D. |
|
Life Science Adviros, Connecticut Innovations
Rocky Hill, CT |
|
| Robert H. Lenox, M.D. |
|
Vice President & Head, CNS Discovery
Aventis Pharmaceuticals |
|
| Mr. Manuel Litchman |
|
Executive Director
Oncololgy Business Development & Licensing
Novartis Pharmaceuticals |
|
| Ms. Jennifer Mandell |
|
Goldman Sachs |
|
| Sharon Mates, Ph.D. |
|
Chairman & CEO, Intra-Cellular Technologies
New York, NY |
|
| Mr. Paul McCracken |
|
Director, UBS; New York, NY |
|
| Clive A. Meanwell, M.D., Ph.D. |
|
Chairman, President & CEO
The Medicines Company |
|
| Dr. Ruchi Mehta |
|
Managing Director, Lone Pine Capital; Greenwich, CT |
|
| Mrs. Karen Gordon Mills |
|
Managing Director, Solera Capital, LLC; New York, NY |
|
| James E. Neidel, M.D. |
|
Venture Partner, Healthcare Technology
Sprout Group; New York, NY |
|
| Stelios Pappadopoulos, Ph.D. |
|
Vice Chairman, SG Cowen |
|
| Mr. Dennis J. Purcell |
|
Senior Managing Director, Perseus-Soros Biopharmaceutical Fund |
|
| Yi Ri, M.D., Ph.D. |
|
Analyst, S-Squared Technology Corp.; New York, NY |
|
| Dr. Steven Rosenfeld |
|
Stone Rock Biomedical, LP |
|
| Ms. Monique Salazar |
|
Assistant Vice President, Biosciences
NYC Economic Development Corporation |
|
| Ms. Annabel Samimy |
|
Associate Director, UBS; New York, NY |
|
| Mr. Jordan Schreiber |
|
Managing Director, Merrill Lynch Investment Managers; Plainsboro, NJ |
|
| H. Scott Silverman, D.Phil. |
|
Senior Associate, Atlas Venture; Waltham, MA |
|
| Mr. Mark Simon |
|
Managing Director, Health Care Group
Citigroup Global Investment Management |
|
| Mr. Geoffrey Smith |
|
Managing Director, Ascent Biomedical Ventures, L.P. |
|
| Michael Steiner, Ph.D. |
|
Director & Global Leader of the Healthcare Practice
Bain & Company, Inc. |
|
| Ms. Deborah Stiles |
|
Vice President for Research Operations,
Columbia University |
|
| David Stoffel, M.D. |
|
Radius Ventures |
|
| Mr. David Sudolsky |
|
President/CEO, ProCertus BioPharm |
|
| Mr. Philip N. Sussman |
|
Managing Partner, The Channel Group; Bedford, NY |
|
| Dr. Lorne Taichman |
|
Constultant, Johnson & Johnson, COSAT Group |
|
| Mr. Richard van den Broek |
|
DCF Capital L.L.C. |
|
| Ravi Viswanathan, Ph.D. |
|
Principal, NEA; Reston, VA |
|
| Alan G. Walton, Ph.D., D.Sc. |
|
Senior General Partner, Oxford Bioscience Partners
Westport, CT |
|
| Lawrence P. Wennogle, Ph.D. |
|
Vice President, Drug Discovery
Intra-cellular Technologies |
|
| Mr. Harold R. Werner |
|
Managing Director; HealthCare Ventures LLC |
|
| Brett Zbar, M.D. |
|
Perseus-Soros Biopharmaceutical Fund
New York, NY |
|
 |
|
|
| Dr. Larry D. Altstiel, '79 |
|
VP Research Operations, Eisai Global Clinical Development |
|
| Dr. Adriane M. Antler, '86 |
|
Partner, Jones Day; New York |
|
| Dr. Claudio Bertuccioli, '96 |
|
Principal, Rho Capital Partners, Inc. |
|
| Dr. Dean L. Engelhardt, '67 |
|
Executive Vice President, Enzo Biochem, Inc.;
New York, NY |
|
| Dr. Libbe L. Englander, '87 |
|
BioPharma Capital; New York, NY |
|
| Dr. Lisa B. Kole, '85 |
|
Partner, Baker Botts LLP; New York, NY |
|
| Dr. Teena L. Lerner, '83 |
|
CEO, Rx Capital Management LP |
|
| Dr. Daniel R. Marshak, '83 |
|
VP and Chief Technology Officer, Biotechnology,
Cambrex Bio Science Baltimore |
|
| Dr. Cheng-Kon Shih, '85 |
|
Senior Principal Scientist, Boehringer-Ingelheim Pharmaceuticals, Inc. |
|
| Dr. Arthur H. Tinkelenberg, '96 |
|
Principal, Ascent Biomedical Ventures, L.P. |
|
 |
|
|
| C. David Allis, Ph.D. |
|
Joy and Jack Fishman Professor & Head
Laboratory of Chromatin Biology and Epigenetics |
|
| Barry S. Coller, M.D. |
|
David Rockefeller Professor
Physician-in-Chief
Vice President for Medical Affairs |
|
| Kathleen A. Denis, Ph.D. |
|
Associate Vice President for Technology Transfer |
|
| Mr. Philip DiMauro |
|
Senior Director, Grants and Stewardship |
|
| Ms. Carol B. Einiger |
|
Vice President and Chief Investment Officer |
|
| Ms. Maren E. Imhoff |
|
Vice President for Development |
|
|
| Ms. Lisa A. Kressbach |
|
Director, RU Council Initiative |
|
| Ms. Vickie L. Lister |
|
Senior Director, Planned Giving and Committee on Trust and Estate Gift Plans |
|
| Dr. F. Nina Papavasiliou, '98 |
|
Assistant Professor & Head
Laboratory of Lymphocyte Biology |
|
| Ms. Jane Rendall |
|
Corporate Secretary |
|
| Ms. Karen Ann Smith |
|
Senior Director, Major Gifts |
|
| Dr. Tari Suprapto, '02 |
|
Manager, Technology Transfer |
|
| Ms. Catherine Vanchieri |
|
Senior Director, Development Communications and Science Writing |
|
| Dr. Michael W. Young |
|
Vice President for Academic Affairs
Richard and Jeanne Fisher Professor & Head
Laboratory of Genetics |
